An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.

Australia's vaccination rates against COVID and influenza are below ideal figures, but could a future innovation be able to ...

Medical clinics in the western Bay of Plenty area are experiencing a spike in people presenting with influenza and Covid-19 ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

PRN02047 To: integrated care boards – chief executives GP practices community pharmacies primary care networks NHS trusts – chief executives local government chief executives health and justice ...

Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

Solid phase III efficacy results for Moderna Inc.’s seasonal influenza vaccine, mRNA-1010, may lead the company to resubmit a ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...

Many of the protections and behaviours that helped us during the pandemic — like staying home when sick, wearing masks, and ...